Cited by 2,489Cardiac electrophysiology and arrhythmiasCardiac pacing and defibrillation studiesCardiac Arrhythmias and Treatments

The DOI matches its Crossref record, with a small difference in title or year; 34 of the 34 references it cites were found in a registry or an index.

A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease

Open access

Buxton, Alfred E., Lee, Kerry L., Fisher, John D., Josephson, Mark E., Prystowsky, Eric N., Hafley, Gail·1999·New England Journal of Medicine

DOI 10.1056/nejm199912163412503

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Empirical antiarrhythmic therapy has not reduced mortality among patients with coronary artery disease and asymptomatic ventricular arrhythmias. Previous studies have suggested that antiarrhythmic therapy guided by electrophysiologic testing might reduce the risk of sudden death. METHODS: We conducted a randomized, controlled trial to test the hypothesis that electrophysiologically guided antiarrhythmic therapy would reduce the risk of sudden death among patients with coronary artery disease, a left ventricular ejection fraction of 40 percent or less, and asymptomatic, unsustained ventricular tachycardia. Patients in whom sustained ventricular tachyarrhythmias were induced by programmed stimulation were randomly assigned to receive either antiarrhythmic therapy, including drugs and implantable defibrillators, as indicated by the results of electrophysiologic testing, or no antiarrhythmic therapy. Angiotensin-converting-enzyme inhibitors and beta-adrenergic-blocking agents were administered if the patients could tolerate them. RESULTS: A total of 704 patients with inducible, sustained ventricular tachyarrhythmias were randomly assigned to treatment groups. Five-year Kaplan-Meier estimates of the incidence of the primary end point of cardiac arrest or death from arrhythmia were 25 percent among those receiving electrophysiologically guided therapy and 32 percent among the patients assigned to no antiarrhythmic therapy (relative risk, 0.73; 95 percent confidence interval, 0.53 to 0.99), representing a reduction in risk of 27 percent). The five-year estimates of overall mortality were 42 percent and 48 percent, respectively (relative risk, 0.80; 95 percent confidence interval, 0.64 to 1.01). The risk of cardiac arrest or death from arrhythmia among the patients who received treatment with defibrillators was significantly lower than that among the patients discharged without receiving defibrillator treatment (relative risk, 0.24; 95 percent confidence interval, 0.13 to 0.45; P<0.001). Neither the rate of cardiac arrest or death from arrhythmia nor the overall mortality rate was lower among the patients assigned to electrophysiologically guided therapy and treated with antiarrhythmic drugs than among the patients assigned to no antiarrhythmic therapy. CONCLUSIONS: Electrophysiologically guided antiarrhythmic therapy with implantable defibrillators, but not with antiarrhythmic drugs, reduces the risk of sudden death in high-risk patients with coronary disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199912163412503

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,244
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
The AVID Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,221
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
Julian, D. G., CAMM, A. J., Frangin, G., Janse, M. J., Munoz, A., Pj, S., & Simon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09145-3 · Cited by 1,100

Show all 34 references

Research works printed but not linked: 1

10.2307/2281868 · DOI · Paper page

Sorted by citations

Items 101–200 of 1,000

Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Results of a Prospective, Multinational Registry
Lampert, R., Olshansky, B., Heidbuchel, H., Lawless, C., Saarel, E., Ackerman, M., Calkins, H., Estes, N. A. M., Link, M. S., Maron, B. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000447 · Cited by 286
“Total, n (%) 49/36 (10) 39/29 (8) 33/23 (6) 121/77 (21)”
Complications Associated With Implantable Cardioverter-Defibrillator Replacement in Response to Device Advisories
Gould, P. A. (2006) · JAMA · doi:10.1001/jama.295.16.1907 · Cited by 284
Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies
Goldberger, Z., & Lampert, R. (2006) · JAMA · doi:10.1001/jama.295.7.809 · Cited by 271
Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients
Sweeney, M. O., Wathen, M. S., VOLOSIN, K. J., Abdalla, I., DeGroot, P., Otterness, M. F., & Stark, A. J. (2005) · Circulation · doi:10.1161/circulationaha.104.526673 · Cited by 275
A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification
Gold, M. R., Bloomfield, D. M., Anderson, K. P., El‐Sherif, N., Wilber, D. J., Groh, W. J., Estes, N. A. M., Kaufman, E. S., Greenberg, M. L., & ROSENBAUM, D. S. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01017-2 · Cited by 275
“Recently, programmed ventricular stimulation during electrophysiology (EPS) testing (6,7), but not signal averaged electrocardiography (SAECG) (8), identified a cohort with left ventricular dysfunction who had improved survival with implantable cardioverter-defibrillator (ICD) placement.”
Background
Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline
Heart Failure Society of America (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.04.005 · Cited by 284
Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction
Bloomfield, D. M., Bigger, J. T., Steinman, R. C., Namerow, P. B., Parides, M. K., Curtis, A. B., Kaufman, E. S., Davidenko, J. M., Shinn, T., & Fontaine, J. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.026 · Cited by 270
Implantable Cardioverter Defibrillators in Primary and Secondary Prevention
Ezekowitz, J. A., Armstrong, P. W., & McAlister, F. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-6-200303180-00007 · Cited by 264
Prediction of sudden cardiac death after acute myocardial infarction: Role of Holter monitoring in the modern treatment era
Mäkikallio, T. H., Barthel, P., Schneider, R., Bauer, A., Tapanainen, J. M., Tulppo, M. P., Schmidt, G., & Huikuri, H. V. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi188 · Cited by 249
Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era
Huikuri, H. V., Tapanainen, J. M., Lindgren, K. S., Raatikainen, P. M. J., Mäkikallio, T. H., Airaksinen, J. K. E., & Myerburg, R. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00783-6 · Cited by 251
Sudden Cardiac Death and Arrhythmias
Srinivasan, N. T., & SCHILLING, R. J. (2018) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2018:15:2 · Cited by 249
The ABCD (Alternans Before Cardioverter Defibrillator) Trial
Costantini, O., Hohnloser, S. H., KIRK, M. M., Lerman, B. B., Baker, J. H., Sethuraman, B., Dettmer, M. M., & ROSENBAUM, D. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.077 · Cited by 247
Clinical Trials Update and Cumulative Meta-Analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and Cardiac Resynchronisation Therapy in Heart Failure
Cleland, J. G. F., GHOSH, J. M., Freemantle, N., Kaye, G., Nasir, M., Clark, A. L., & Coletta, A. P. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.04.014 · Cited by 241
Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure
Packer, D. L., Prutkin, J. M., Hellkamp, A. S., Mitchell, L. B., Bernstein, R. C., Wood, F., BOEHMER, J. P., Carlson, M. D., Frantz, R. P., McNulty, S. E., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.853689 · Cited by 243
Self-citation
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
Wilkoff, B. L., Fauchier, L., Stiles, M. K., Morillo, C. A., Al‐Khatib, S. M., Almendral, J. M., Aguinaga, L., Berger, R. D., Cuesta, A., Daubert, J. P., et al. (2015) · EP Europace · doi:10.1093/europace/euv411 · Cited by 243
“The efficacy of the ICD for the primary and secondary prevention of SCD has been well established in several landmark clinical trials [180–185].”
Background
Postoperative Arrhythmias after Cardiac Surgery: Incidence, Risk Factors, and Therapeutic Management
Peretto, G., Durante, A., Limite, L. R., & Cianflone, D. (2014) · Cardiology Research and Practice · doi:10.1155/2014/615987 · Cited by 243
Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: A MADIT-II substudy
Sesselberg, H. W., Moss, A. J., McNitt, S. A., Zaręba, W., Daubert, J. P., Andrews, M. L., Hall, W. J., McClinitic, B., & Huang, D. T.-C. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.07.013 · Cited by 237
Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: effect of endurance exercise training
Billman, G. E. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00534.2009 · Cited by 237
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
Epstein, A. E., Dimarco, J., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.033 · Cited by 240
Association of Short-term Ambient Air Pollution Concentrations and Ventricular Arrhythmias
Rich, D. Q., Schwartz, J. D., Mittleman, M. A., Link, M. S., Luttmann‐Gibson, H., Catalano, P. J., Speizer, F. E., & Dockery, D. W. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi143 · Cited by 232
Long-Term Benefit of Primary Prevention With an Implantable Cardioverter-Defibrillator
Goldenberg, I., Gillespie, J. A., Moss, A. J., Hall, W. J., Klein, H., McNitt, S. A., Brown, M. W., Cygankiewicz, I., & Zaręba, W. (2010) · Circulation · doi:10.1161/circulationaha.110.940148 · Cited by 230
Practical Guidelines for Multiplicity Adjustment in Clinical Trials
Proschan, M. A., & Waclawiw, M. A. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00106-9 · Cited by 226
“The Multi-Center Unsustained Tachycardia Trial (MUSTT) randomized patients with coronary artery disease and asymptomatic, unsustained ventricular tachycardia to either no antiarrhythmic therapy or antiarrhythmic therapy guided by electrophysiologic testing [13].”
Method
Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure
Lindenfeld, J. M., Feldman, A. M., Saxon, L. A., BOEHMER, J. P., Carson, P. E., Ghali, J. K., Anand, I. S., Singh, S., Steinberg, J. S., Jaski, B. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.629261 · Cited by 225
Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial
Gold, M. R., Lambiase, P. D., El‐Chami, M. F., Knops, R. E., Aasbo, J. D., Bongiorni, M. G., Russo, A. M., Deharo, J., Burke, M. C., DINERMAN, J. L., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.048728 · Cited by 225
Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defibrillators and Their Families: A Scientific Statement From the American Heart Association
Dunbar, S. B., Dougherty, C. M., Sears, S. F., Carroll, D. L., Goldstein, N. E., Mark, D. B., McDaniel, G., Pressler, S. J., Schron, E., Wang, P., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31825d59fd · Cited by 221
The Cost Effectiveness of Implantable Cardioverter-Defibrillators
Zwanziger, J., Hall, W. J., Dick, A. W., Zhao, H., Mushlin, A. I., Hahn, R., Wang, H., Andrews, M. L., Mooney, C., Wang, H., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.032 · Cited by 221
Secondary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults
Fleg, J. L., Forman, D. E., Berra, K. A., Bittner, V., Blumenthal, J. A., Chen, M. A., Cheng, S. C., Kitzman, D. W., Maurer, M. S., Rich, M. W., et al. (2013) · Circulation · doi:10.1161/01.cir.0000436752.99896.22 · Cited by 225
Frequency and Causes of Implantable Cardioverter-Defibrillator Therapies: Is Device Therapy Proarrhythmic?
Germano, J. J., Reynolds, M. R., Essebag, V., & Josephson, M. E. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.048 · Cited by 215
Self-citation
The epidemiology of out-of-hospital ‘sudden’ cardiac arrest
Engdahl, J., Holmberg, M., Karlson, B. W., Luepker, R. V., & Herlitz, J. D. (2002) · Resuscitation · doi:10.1016/s0300-9572(01)00464-6 · Cited by 221
“[66] Multicenter Unsustained Tachycardia Trial Investigators, Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN,”
Background
Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction
Nanthakumar, K., Epstein, A. E., Kay, G. N., Plumb, V. J., & Lee, D. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.054 · Cited by 216
Effectiveness of Implantable Cardioverter-Defibrillators for the Primary Prevention of Sudden Cardiac Death in Women With Advanced Heart Failure
Ghanbari, H. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.255 · Cited by 213
How Sudden Is Sudden Cardiac Death?
Müller, D., Agrawal, R., & Arntz, H.-R. (2006) · Circulation · doi:10.1161/circulationaha.106.616318 · Cited by 213
Cardiac Resynchronization Therapy
Bax, J. J., Abraham, T. P., Barold, S. S., Breithardt, O. A., Fung, J. W., Garrigue, S., Gorcsan, J., Hayes, D. L., Kass, D. A., Knuuti, J. M., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.020 · Cited by 209
Recalls and Safety Alerts Involving Pacemakers and Implantable Cardioverter-Defibrillator Generators
Maisel, W. H. (2001) · JAMA · doi:10.1001/jama.286.7.793 · Cited by 210
Relations Among Renal Function, Risk of Sudden Cardiac Death, and Benefit of the Implanted Cardiac Defibrillator in Patients With Ischemic Left Ventricular Dysfunction
Goldenberg, I., Moss, A. J., McNitt, S. A., Zaręba, W., Andrews, M. L., Hall, W. J., Greenberg, H., & Case, R. B. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.03.025 · Cited by 209
Ventricular Tachycardia and Sudden Cardiac Death
Koplan, B. A., & Stevenson, W. G. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.3.289 · Cited by 215
Perioperative management of patients with cardiac implantable electronic devices
Stone, M. E., Salter, B. S., & Fischer, A. (2011) · British Journal of Anaesthesia · doi:10.1093/bja/aer354 · Cited by 206
Implantable Defibrillators and Sudden Cardiac Death
Josephson, M. E., & Wellens, H. J. J. (2004) · Circulation · doi:10.1161/01.cir.0000129322.97266.f3 · Cited by 207
Self-citation
JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias
Nogami, A., Kurita, T., Abe, H., Andò, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0637 · Cited by 205
Does Microvolt T-Wave Alternans Testing Predict Ventricular Tachyarrhythmias in Patients With Ischemic Cardiomyopathy and Prophylactic Defibrillators?
Chow, T., Kereiakes, D. J., Onufer, J., Woelfel, A., Gursoy, S., Peterson, B. J., Brown, M. L., Pu, W., & Benditt, D. G. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.018 · Cited by 201
Part 8: Advanced life support
Deakin, C. D., Morrison, L. J., Morley, P. T., Callaway, C. W., Kerber, R. E., Kronick, S. L., Lavonas, E. J., Link, M. S., Neumar, R. W., Otto, C. W., et al. (2010) · Resuscitation · doi:10.1016/j.resuscitation.2010.08.027 · Cited by 205
Gender Differences in Procedure-Related Adverse Events in Patients Receiving Implantable Cardioverter-Defibrillator Therapy
Peterson, P. N., Daugherty, S. L., Wang, Y., Vidaillet, H. J., Jr., Heidenreich, P. A., Curtis, J. P., & Masoudi, F. A. (2009) · Circulation · doi:10.1161/circulationaha.108.793463 · Cited by 196
Brugada syndrome: 1992–2002
Antzelevitch, C. N., Brugada, P., Brugada, J., Brugada, R., Towbin, J. A., & Nademanee, K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00310-3 · Cited by 193
Remote Monitoring of Implantable Cardioverter Defibrillators: A Prospective Analysis
SCHOENFELD, M. H., COMPTON, S. J., MEAD, R. H., WEISS, D. N., SHERFESEE, L., ENGLUND, J., & MONGEON, L. R. (2004) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2004.00524.x · Cited by 194
Effectiveness of implantable defibrillators for preventing arrhythmic events and death
Lee, D. S., Green, L. D., Liu, P. P., Dorian, P., Newman, D. M., Grant, F., Tu, J. V., & Alter, D. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00253-5 · Cited by 195
Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic Dysfunction: Primary Results From the T-Wave Alternans Sudden Cardiac Death in Heart Failure Trial Substudy
Gold, M. R., Ip, J. H., Costantini, O., Poole, J. E., McNulty, S., Mark, D. B., Lee, K. L., & Bardy, G. H. (2008) · Circulation · doi:10.1161/circulationaha.107.748962 · Cited by 193
Self-citation
Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk)
Bauer, A., Barthel, P., Schneider, R., Ulm, K., Müller, A., Joeinig, A., Stich, R., Kiviniemi, A. M., Hnatkova, K., Huikuri, H. V., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn540 · Cited by 192
The Relation Between Patients’ Outcomes and the Volume of Cardioverter-Defibrillator Implantation Procedures Performed by Physicians Treating Medicare Beneficiaries
Al‐Khatib, S. M., Lucas, F. L., Jollis, J. G., Malenka, D. J., & Wennberg, D. E. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.063 · Cited by 193
Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion?
Russo, A. M., Sauer, W. H., Gerstenfeld, E. P., Hsia, H. H., Lin, D., Cooper, J. M., Dixit, S., Verdino, R. J., Nayak, H. M., Callans, D. J., et al. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.01.015 · Cited by 191
Predictive Value of Ventricular Arrhythmia Inducibility for Subsequent Ventricular Tachycardia or Ventricular Fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Patients
Daubert, J. P., Zaręba, W., Hall, W. J., Schuger, C. D., Corsello, A. C., León, A. R., Andrews, M. L., McNitt, S. A., Huang, D. T.-C., & Moss, A. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.049 · Cited by 191
“rials (2,3) excluded noninducible patients on the basis of”
Background
Summary of Recommendations
Priori, S. G. (2002) · EP Europace · doi:10.1053/eupc.2001.0214 · Cited by 192
Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction
Bailey, J. J., Berson, A. S., Handelsman, H., & Hodges, M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01667-9 · Cited by 187
Electrocardiographic Predictors of Arrhythmic Death and Total Mortality in the Multicenter Unsustained Tachycardia Trial
ZIMETBAUM, P. J., Buxton, A. E., Batsford, W. P., Fisher, J. D., Hafley, G. E., Lee, K. L., O’Toole, M. F., Page, R. L., Reynolds, M. R., & Josephson, M. E. (2004) · Circulation · doi:10.1161/01.cir.0000139311.32278.32 · Cited by 186
Self-citation
Aerobic exercise conditioning: a nonpharmacological antiarrhythmic intervention
Billman, G. E. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00874.2001 · Cited by 185
“The 1-yr mortality is 10% or higher with sudden death, accounting for approximately one-third of the deaths in these high-risk patients (27).”
Background
Noninvasive Electroanatomic Mapping of Human Ventricular Arrhythmias with Electrocardiographic Imaging
Wang, Y., Cuculich, P. S., Zhang, J., Desouza, K. A., Vijayakumar, R., Chen, J., Faddis, M. N., Lindsay, B. D., Smith, T. W., & Rudy, Y. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002152 · Cited by 190
Association of Physician Certification and Outcomes Among Patients Receiving an Implantable Cardioverter-Defibrillator
Curtis, J. P. (2009) · JAMA · doi:10.1001/jama.2009.547 · Cited by 181
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death—Executive Summary
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.008 · Cited by 184
“ICD therapy is indicated to reduce the risk of SCD in 2 patient groups: patients whose LVEF is less than or equal to 40% as a result of prior MI and who have spontaneous NSVT and sustained monomorphic VT inducible by EP testing (50) and patients whose LVEF is less than 30% as a result of an MI that occurred greater th…”
BackgroundResultSelf-citation
Current Smoking, Smoking Cessation, and the Risk of Sudden Cardiac Death in Patients With Coronary Artery Disease
Goldenberg, I. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.19.2301 · Cited by 178
“Despite the advances in the prediction of SCD in survivors of MI, the effect on the cumulative incidence of SCD in patients with CAD or previous MI has been relatively small, because most SCDs occur among patients without the characteristics that would have led to their inclusion in trials of implantable defibrillator…”
Background
Amiodarone: guidelines for use and monitoring.
Siddoway, L. A. (2003) · PubMed · Cited by 180
Analysis of Implantable Cardioverter Defibrillator Therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial
Klein, R. C., Raitt, M. H., Wilkoff, B. L., Beckman, K. J., Coromilas, J., Wyse, D. G., Friedman, P. L., Martins, J. B., Epstein, A. E., Hallstrom, A. P., et al. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.01554.x · Cited by 179
“All therapies 157 (8) 734 (36) 253 (12) 59 (3) 37 (2) 5 (0) 812 (39)”
Influential
Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines
Carlson, M. D., Wilkoff, B. L., Maisel, W. H., Carlson, M. D., Ellenbogen, K. A., Saxon, L. A., Prystowsky, E. N., Alpert, J. S., Cain, M. E., Ching, E. A., et al. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.08.029 · Cited by 177
Self-citation
The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)
Hodgkinson, K. A., Parfrey, P. S., Bassett, A. S., Kupprion, C., Drenckhahn, J., Norman, M. W., Thierfelder, L., Stuckless, S. N., Dicks, E. L., McKenna, W. J., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.068 · Cited by 177
Prediction of Sudden Cardiac Death
Huikuri, H. V., Mäkikallio, T. H., Raatikainen, M. J. P., Perkiömäki, J. S., Castellanos, A., & Myerburg, R. J. (2003) · Circulation · doi:10.1161/01.cir.0000077519.18416.43 · Cited by 177
Abnormal Sympathetic Innervation of Viable Myocardium and the Substrate of Ventricular Tachycardia After Myocardial Infarction
Sasano, T., Abraham, M. R., Chang, K., Ashikaga, H., Mills, K. J., Holt, D. P., Hilton, J., Nekolla, S. G., Dong, J., Lardo, A. C., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.062 · Cited by 176
Prediction of Long-Term Outcomes by Signal-Averaged Electrocardiography in Patients With Unsustained Ventricular Tachycardia, Coronary Artery Disease, and Left Ventricular Dysfunction
Gomes, J. A., CAIN, M. E., Buxton, A. E., Josephson, M. E., Lee, K. L., & Hafley, G. E. (2001) · Circulation · doi:10.1161/hc2901.093197 · Cited by 176
Self-citation
Sudden cardiac death: epidemiology, pathogenesis and management
Kumar, A., Avishay, D. M., Jones, C. R., Shaikh, J. D., Kaur, R., Aljadah, M. M., Kichloo, A., Shiwalkar, N., & Keshavamurthy, S. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2021.01.207 · Cited by 184
I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator
Arora, R., Ferrick, K. J., Nakata, T., Kaplan, R. C., Rozengarten, M., Latif, F., Ng, K., Marcano, V., Heller, S. L., Fisher, J. D., et al. (2003) · Journal of Nuclear Cardiology · doi:10.1067/mnc.2003.2 · Cited by 174
Self-citation
“That’s Like an Act of Suicide” Patients’ Attitudes Toward Deactivation of Implantable Defibrillators
Goldstein, N. E., Mehta, D., Siddiqui, S. A., Teitelbaum, E. N., Zeidman, J. A., Singson, M., Pe, E., Bradley, E. H., & Morrison, R. S. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0239-8 · Cited by 172
Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction
Ezekowitz, J. A., Rowe, B. H., Dryden, D. M., Hooton, N., Vandermeer, B., Spooner, C., & McAlister, F. A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-4-200708210-00007 · Cited by 172
Clinical Cardiac Electrophysiology
RANKIN, A. C., Quinn, F. R., & Rae, A. P. (2010) · Springer eBooks · doi:10.1007/978-0-85729-877-5_2 · Cited by 170
Status of Women in Cardiovascular Clinical Trials
Kim, E. S. H., & Menon, V. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179796 · Cited by 173
Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: A systematic review and meta-analysis
Santangeli, P., Pelargonio, G., Russo, A. D., Casella, M., Bisceglia, C., Bartoletti, S., Santarelli, P., Biase, L. D., & Natale, A. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.03.042 · Cited by 167
Risk Stratification for Arrhythmic Sudden Cardiac Death
Goldberger, J. J., Buxton, A. E., CAIN, M. E., Costantini, O., Exner, D. V., Knight, B. P., Lloyd‐Jones, D. M., Kadish, A. H., Lee, B. K., Moss, A. J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.959734 · Cited by 167
Self-citation
HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
Kusumoto, F. M., Calkins, H. G., BOEHMER, J. P., Buxton, A. E., Chung, M. K., Gold, M. R., Hohnloser, S. H., Indik, J. H., Lee, R., Mehra, M. R., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.008 · Cited by 170
Self-citation
Meta-analysis: Age and Effectiveness of Prophylactic Implantable Cardioverter-Defibrillators
Santangeli, P., Biase, L. D., Russo, A. D., Casella, M., Bartoletti, S., Santarelli, P., Pelargonio, G., & Natale, A. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-9-201011020-00009 · Cited by 167
JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias
Nogami, A., Kurita, T., Abe, H., Andò, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12491 · Cited by 166
Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis
Theuns, D. A. M. J., Smith, T. W., Hunink, M. G. M., Bardy, G. H., & Jordaens, L. J. L. M. (2010) · EP Europace · doi:10.1093/europace/euq329 · Cited by 163
“The Multicenter Unsustained Tachycardia Trial (MUSTT) and the Comparison of Medical Therapy, Pacing and Defibrillators in Chronic Heart Failure (COMPANION) trial were excluded from the analysis.(21,22) The MUSTT trial was not a randomized controlled trial of ICD therapy, but compared with electrophysiological study gu…”
Cardiac Arrest and Sudden Cardiac Death
Myerburg, R. J., & Castellanos, A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00041-x · Cited by 166
Stage B Heart Failure
Goldberg, L. R., & Jessup, M. L. (2006) · Circulation · doi:10.1161/circulationaha.105.600437 · Cited by 165
Cardiac Arrhythmias: Diagnosis, Symptoms, and Treatments
Fu, D.-G. (2015) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-015-0626-4 · Cited by 180
“Some useful readings have also been mentioned [22–25].”
Background
Demographics and concomitant disorders in heart failure
Krum, H., & Gilbert, R. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13869-x · Cited by 161
Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy
Gatzoulis, K. A., ANDRIKOPOULOS, G., Apostolopoulos, T., Sotiropoulos, E., Zervopoulos, G., Antoniou, J. D., Brili, S., & Stefanadis, C. (2005) · EP Europace · doi:10.1016/j.eupc.2005.01.003 · Cited by 160
“ES is expected to occur in almost one of five patients treated with an ICD for the secondary prevention of SCD when the period of observation exceeds 3 years.”
MethodInfluential
Short-term results of substrate mapping and radiofrequency ablation of ischemic ventricular tachycardia using a saline-irrigated catheter
Reddy, V. Y., Neužil, P., Táborský, M., & Ruskin, J. N. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00492-3 · Cited by 158
Ventricular Tachycardia Ablation
Guandalini, G. S., Liang, J. J., & Marchlinski, F. E. (2019) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2019.09.015 · Cited by 162
Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators
Lampert, R. J., Olshansky, B., Heidbüchel, H., Lawless, C. E., Saarel, E. V., Ackerman, M. J., Calkins, H. G., Estes, N. A. M., Link, M. S., Maron, B. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.027828 · Cited by 156
High Incidence of Appropriate and Inappropriate ICD Therapies in Children and Adolescents with Implantable Cardioverter Defibrillator
Korte, T., Köditz, H., NIEHAUS, M., Paul, T., & Tebbenjohanns, J. (2004) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2004.00560.x · Cited by 155
Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States
Friedman, D. J., Parzynski, C. S., Varosy, P. D., Prutkin, J. M., Patton, K. K., Mithani, A. A., Russo, A. M., Curtis, J. P., & Al‐Khatib, S. M. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2782 · Cited by 155
Integrating quality into the cycle of therapeutic development
Califf, R. M., Peterson, E. D., Gibbons, R. J., Garson, A., Brindis, R. G., Beller, G., & Smith, S. C. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02537-8 · Cited by 155
“The fact that cost does affect therapeutic choice has produced a crisis, however, as illustrated by the escalation of healthcare costs versus the increasing imperatives to implant defibrillators (7,8), coated stents (6), or left ventricular assist devices (9).”
Background
The implantable cardioverter defibrillator
Glikson, M., & Friedman, P. A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04263-x · Cited by 155
Secondary prevention with folic acid: effects on clinical outcomes
Liem, A. H., Reynierse-Buitenwerf, G. H., Zwinderman, A. H., Jukema, J. W., & van Veldhuisen, D. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00485-6 · Cited by 150
Improved Survival Associated with Prophylactic Implantable Defibrillators in Elderly Patients with Prior Myocardial Infarction and Depressed Ventricular Function: A MADIT‐II Substudy
Huang, D. T.-C., Sesselberg, H. W., McNitt, S. A., Noyes, K., Andrews, M. L., Hall, W. J., Dick, A. W., Daubert, J. P., Zaręba, W., & Moss, A. J. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00857.x · Cited by 147
Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial
Fitchet, A., Doherty, P. J., Bundy, C., Bell, W., Fitzpatrick, A. P., & Garratt, C. J. (2003) · Heart · doi:10.1136/heart.89.2.155 · Cited by 147
Predicting Ventricular Arrhythmias in Patients With Ischemic Heart Disease
Borleffs, C. J. W., Scherptong, R. W. C., Man, S., van Welsenes, G. H., Bax, J. J., van Erven, L., Swenne, C. A., & Schalij, M. J. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.859108 · Cited by 146
Risk Stratification for Sudden Cardiac Death
Goldberger, J. J., Basu, A., Boineau, R., Buxton, A. E., CAIN, M. E., Canty, J. M., Chen, P., Chugh, S. S., Costantini, O., Exner, D. V., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007149 · Cited by 143
Self-citation
Cardiac surgery: Postoperative arrhythmias
Chung, M. K. (2000) · Critical Care Medicine · doi:10.1097/00003246-200010001-00005 · Cited by 142
“In the Multicenter Unsustained Tachycardia Trial (MUSTT) (48), patients with coronary artery disease, left ventricular ejection fraction #40%, nonsustained ventricular tachycardia, and inducible sustained ventricular tachycardia were randomized to electrophysiologic-guided therapy vs. standard therapy (angiotensin-con…”
BackgroundMethodResultInfluential
Ventricular tachyarrhythmia associated with cardiac sarcoidosis: Its mechanisms and outcome
Furushima, H., Chinushi, M., Sugiura, H., Kasai, H., Washizuka, T., & Aizawa, Y. (2004) · Clinical Cardiology · doi:10.1002/clc.4960270409 · Cited by 141
Trends in Use of Implantable Cardioverter-Defibrillator Therapy Among Patients Hospitalized for Heart Failure
Al‐Khatib, S. M., Hellkamp, A. S., Hernandez, A. F., Fonarow, G. C., Thomas, K. L., Al‐Khalidi, H. R., Heidenreich, P. A., Hammill, S. C., Yancy, C. W., & Peterson, E. D. (2012) · Circulation · doi:10.1161/circulationaha.111.066605 · Cited by 139
Implantable Cardioverter–Defibrillators after Myocardial Infarction
Myerburg, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0803409 · Cited by 136
Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators
Brigadeau, F., Kouakam, C., Klug, D., Marquié, C., Duhamel, A., Mizon-Gérard, F., Lacroix, D., & Kacet, S. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi726 · Cited by 136
Risk Factors for Mortality in Patients With Cardiac Device-Related Infection
Baman, T. S., Gupta, S. K., Valle, J. A., & Yamada, E. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.816868 · Cited by 137
“Biventricular PM/ICD 15 (7) 10 (6) 5 (14) 1.”

Authors: Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G.
Affiliations: Brown University (US)
Duke University (US)
Albert Einstein College of Medicine (US)
Beth Israel Deaconess Medical Center (US)
ORCID: Buxton, Alfred E.
Lee, Kerry L.
Fisher, John D.
Prystowsky, Eric N.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1999-12-16
Volume: 341
Issue: 25
Pages: 1882-1890
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199912163412503
OpenAlex: W2313547185
Cited by: 2,489
References: 34
Citations by year: 2026: 20 · 2025: 36 · 2024: 23 · 2023: 34 · 2022: 44 · 2021: 41 · 2020: 51 · 2019: 54 · 2018: 54 · 2017: 92 · 2016: 75 · 2015: 87 · 2014: 95 · 2013: 114 · 2012: 122
FWCI: 70.29
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5u01hl045726-06)
National Heart, Lung, and Blood Institute (UO1HL45700, UO1-HL45726, U01HL045700)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Keywords: coronary artery disease, asymptomatic ventricular arrhythmia, implantable cardioverter-defibrillator, antiarrhythmic drugs, electrophysiologic testing, programmed electrical stimulation, cardiac arrest, all-cause mortality, left ventricular ejection fraction, ACE inhibitors, beta-blockers
MeSH terms: Aged, Anti-Arrhythmia Agents, Cardiac Pacing, Artificial, Coronary Disease, Electrophysiology, Female, Humans, Male, Middle Aged, Survival Analysis, Death, Sudden, Cardiac, Defibrillators, Implantable, Tachycardia, Ventricular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks